SEC Form 4 · accession 0001627255-15-000001
Skye Bioscience, Inc. · SKYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian D Ladin
10% Owner
Period of report
Apr 8, 2015
Accepted (ET)
Apr 10, 2015 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 8, 2015 | S | 23,000 | $4.691 | D | 276,728 | I | See Footnote #1 |
| Common StockF1 | Apr 8, 2015 | S | 15,800 | $4.79 | D | 260,928 | I | See Footnote #1 |
| Common StockF1 | Apr 10, 2015 | S | 11,830 | $4.929 | D | 249,098 | I | See Footnote #1 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock directly beneficially owned by BRL TX-Family LP.
Remarks
Mr. Ladin disclaims beneficial ownership of any securities reported herein except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed on admission of beneficial ownership of all such shares for purposes of section 16 or for any other purpose.